This new formulation, which targets both the serotonin 5-HT4 receptor (5-HT4R) and the NMDA receptor (NMDAR), has shown ...

as well as its product registration strategies. "We are thrilled to welcome Gregg to the MindMed team. His leadership will ...

This new formulation, which targets both the serotonin 5-HT4 receptor (5-HT4R) and the NMDA receptor (NMDAR), has shown potential as a treatment for major depressive disorder (MDD), and other severe ...

In September, nine of us gathered in a seminar room in Lattes, in southern France, to begin a two-day first aid training. But the class isn't about performing CPR or treating burns. We're here to ...

Adicet Bio, Inc. , a clinical stage biotechnology company discovering and developing allogeneic gamma delta T cell therapies for autoimmune diseases and cancer, today announced that the first LN ...